Skip to main content
Erschienen in: Die Pathologie 1/2019

19.02.2018 | Übersichten

Proposal for an extended pTNM classification of thyroid carcinoma

Commentary on deficits of the 8th edition of the TNM classification

verfasst von: Prof. Dr. K. W. Schmid, S. Synoracki, H. Dralle, C. Wittekind

Erschienen in: Die Pathologie | Sonderheft 1/2019

Einloggen, um Zugang zu erhalten

Abstract

In the 8th edition of the TNM classification of thyroid carcinomas, which was introduced in 2017, carcinomas with minimal extrathyroidal extension are no longer mentioned, which might cause problems. These tumors were explicitly categorized in previous TNM classifications (5–7th editions). Studies on the prognostic relevance of minimal extrathyroidal extension have shown conflicting results. Moreover, the vast majority of these studies retrospectively analyzed only subgroups of thyroid carcinomas (e.g. differentiated thyroid carcinoma, papillary thyroid carcinoma). The proposed subcategorization of the current TNM classification (8th edition) ensures the continuity of the parameter minimal extrathyroidal extension within the TNM categorization of thyroid carcinomas and also offers the possibility to prospectively analyze in a standardized manner the potential biological relevance of minimal extrathyroidal extension in relation to tumor categories (T/pT category).
Literatur
1.
Zurück zum Zitat Al-Qurayshi Z, Shama MA, Randolph GW, Kandil E (2017) Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer. Endocr Relat Cancer 24:221–226CrossRef Al-Qurayshi Z, Shama MA, Randolph GW, Kandil E (2017) Minimal extrathyroidal extension does not affect survival of well-differentiated thyroid cancer. Endocr Relat Cancer 24:221–226CrossRef
2.
Zurück zum Zitat Amin MB, Greene FL, Edge SB et al (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. Ca Cancer J Clin 67:93–99CrossRef Amin MB, Greene FL, Edge SB et al (2017) The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. Ca Cancer J Clin 67:93–99CrossRef
3.
Zurück zum Zitat Brierley JD, Gospodarowicz MK, Wittekind C (2016) TNM classification of malignant tumours, 8 edn. Wiley-Blackwell, Hoboken, pp 51–54 (Deutsche Übersetzung: Wittekind C (2017) TNM-Klassifikation maligner Tumoren. 8. Auflage. Wiley-VCH, Weinheim) Brierley JD, Gospodarowicz MK, Wittekind C (2016) TNM classification of malignant tumours, 8 edn. Wiley-Blackwell, Hoboken, pp 51–54 (Deutsche Übersetzung: Wittekind C (2017) TNM-Klassifikation maligner Tumoren. 8. Auflage. Wiley-VCH, Weinheim)
4.
Zurück zum Zitat Clain JB, Scherl S, Dos Reis L et al (2014) Extrathyroidal extension prediction extranodal extension in patients with positive lymph nodes: an important association that may affect clinical management. Thyroid 24:951–957CrossRef Clain JB, Scherl S, Dos Reis L et al (2014) Extrathyroidal extension prediction extranodal extension in patients with positive lymph nodes: an important association that may affect clinical management. Thyroid 24:951–957CrossRef
5.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRef Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRef
6.
Zurück zum Zitat Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322CrossRef Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322CrossRef
7.
Zurück zum Zitat Dralle H, Musholt TJ, Schabram J et al (2013) German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 398:347–375CrossRef Dralle H, Musholt TJ, Schabram J et al (2013) German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 398:347–375CrossRef
8.
Zurück zum Zitat Goffredo P, Cheung K, Roman SA, Sosa JA (2013) Can minimally invasive follicular thyroid cancer be approached as a benign lesion? A population-level analysis of survival among 1,200 patients. Ann Surg Oncol 20:767–772CrossRef Goffredo P, Cheung K, Roman SA, Sosa JA (2013) Can minimally invasive follicular thyroid cancer be approached as a benign lesion? A population-level analysis of survival among 1,200 patients. Ann Surg Oncol 20:767–772CrossRef
9.
Zurück zum Zitat Hermann M, Tonninger K, Kober F, Furtlehner EM, Schultheis A, Neuhold N (2010) Minimal-invasives follikuläres Schilddrüsenkarzinom. Chirurg 81:627–635CrossRef Hermann M, Tonninger K, Kober F, Furtlehner EM, Schultheis A, Neuhold N (2010) Minimal-invasives follikuläres Schilddrüsenkarzinom. Chirurg 81:627–635CrossRef
10.
Zurück zum Zitat Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786CrossRef Ito Y, Tomoda C, Uruno T et al (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780–786CrossRef
11.
Zurück zum Zitat Jin BJ, Kim MK, Ji YB, Song CM, Park JH, Tae K (2015) Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma. Oral Oncol 51:759–763CrossRef Jin BJ, Kim MK, Ji YB, Song CM, Park JH, Tae K (2015) Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma. Oral Oncol 51:759–763CrossRef
12.
Zurück zum Zitat Machens A, Dralle H (2015) Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: different biology. Eur J Surg Oncol 41:766–772CrossRef Machens A, Dralle H (2015) Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: different biology. Eur J Surg Oncol 41:766–772CrossRef
13.
Zurück zum Zitat Mete O, Rotstein L, Asa SL (2010) Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 17:386–391CrossRef Mete O, Rotstein L, Asa SL (2010) Controversies in thyroid pathology: thyroid capsule invasion and extrathyroidal extension. Ann Surg Oncol 17:386–391CrossRef
14.
Zurück zum Zitat Moon HJ, Kim EK, Chung WY, Yoon JH, Kwak JY (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18:1916–1923CrossRef Moon HJ, Kim EK, Chung WY, Yoon JH, Kwak JY (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor? Ann Surg Oncol 18:1916–1923CrossRef
15.
Zurück zum Zitat Musholt TJ, Clerici T, Dralle H et al (2011) German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbecks Arch Surg 396:639–649CrossRef Musholt TJ, Clerici T, Dralle H et al (2011) German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbecks Arch Surg 396:639–649CrossRef
16.
Zurück zum Zitat Nikiforov YE, Seethala RR, Tallini G et al (2017) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2:1023–1029CrossRef Nikiforov YE, Seethala RR, Tallini G et al (2017) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2:1023–1029CrossRef
17.
Zurück zum Zitat Park S, Oh C‑M, Cho H et al (2016) Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study. BMJ 355:i5745CrossRef Park S, Oh C‑M, Cho H et al (2016) Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study. BMJ 355:i5745CrossRef
18.
Zurück zum Zitat Radowsky JS, Howard RS, Burch HB, Stojadinovic A (2014) Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome. Thyroid 24:241–244CrossRef Radowsky JS, Howard RS, Burch HB, Stojadinovic A (2014) Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome. Thyroid 24:241–244CrossRef
19.
Zurück zum Zitat Roh JL, Park JW, Jeong J et al (2017) Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma. J Surg Oncol 116:450–458CrossRef Roh JL, Park JW, Jeong J et al (2017) Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma. J Surg Oncol 116:450–458CrossRef
20.
Zurück zum Zitat Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED (2003) Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 11:249–251CrossRef Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED (2003) Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J Surg Pathol 11:249–251CrossRef
21.
Zurück zum Zitat Schmid KW, Wittekind C (2003) Die missglückte Klassifikation. Pathologe 24:338CrossRef Schmid KW, Wittekind C (2003) Die missglückte Klassifikation. Pathologe 24:338CrossRef
22.
Zurück zum Zitat Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385–393CrossRef Schmid KW, Farid NR (2006) How to define follicular thyroid carcinoma? Virchows Arch 448:385–393CrossRef
23.
Zurück zum Zitat Schmid KW, Sheu-Grabellus SY (2016) Schilddrüse. In: Amann K, Kain R, Klöppel G (eds) Pathologie. Urogenitale und Endokrine Organe, Gelenke und Skelett. Springer, Berlin, Heidelberg, pp 631–712 Schmid KW, Sheu-Grabellus SY (2016) Schilddrüse. In: Amann K, Kain R, Klöppel G (eds) Pathologie. Urogenitale und Endokrine Organe, Gelenke und Skelett. Springer, Berlin, Heidelberg, pp 631–712
24.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) TNM classification of malignant tumours, 7 edn. Wiley-Blackwell, Hoboken, pp 58–62 Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) TNM classification of malignant tumours, 7 edn. Wiley-Blackwell, Hoboken, pp 58–62
25.
Zurück zum Zitat Sobin LH, Wittekind Ch (1997) TNM classification of malignant tumours, 5 edn. Wiley-Liss, New York, pp 47–50 Sobin LH, Wittekind Ch (1997) TNM classification of malignant tumours, 5 edn. Wiley-Liss, New York, pp 47–50
26.
Zurück zum Zitat Sobin LH, Wittekind Ch (2002) TNM classification of malignant tumours, 6 edn. Wiley-Liss, New York, pp 52–56 Sobin LH, Wittekind Ch (2002) TNM classification of malignant tumours, 6 edn. Wiley-Liss, New York, pp 52–56
27.
Zurück zum Zitat Su HK, Wenig BM, Haser GC et al (2016) Inter-observer variation in the pathologic identification of minimal extrathyroidal extension in papillary thyroid carcinoma. Thyroid 26:512–517CrossRef Su HK, Wenig BM, Haser GC et al (2016) Inter-observer variation in the pathologic identification of minimal extrathyroidal extension in papillary thyroid carcinoma. Thyroid 26:512–517CrossRef
28.
Zurück zum Zitat Synoracki S, Wittekind C, Dralle H, Schmid KW (2017) Definition der R1-Resektion bei Schilddrüsenkarzinomen. Chirurg 88:740–747CrossRef Synoracki S, Wittekind C, Dralle H, Schmid KW (2017) Definition der R1-Resektion bei Schilddrüsenkarzinomen. Chirurg 88:740–747CrossRef
29.
Zurück zum Zitat WHO (2017) WHO classification of tumours of endocrine organs. In: Lloyd R, Osamura RY, Klöppel G, Rosai J (Hrsg) Tumours of the thyroid gland, 4. Aufl. IARC, Lyon, S 65–143 WHO (2017) WHO classification of tumours of endocrine organs. In: Lloyd R, Osamura RY, Klöppel G, Rosai J (Hrsg) Tumours of the thyroid gland, 4. Aufl. IARC, Lyon, S 65–143
30.
Zurück zum Zitat Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM supplement. A commentary on uniform use, 3 edn. Wiley, New YorkCrossRef Wittekind C, Greene FL, Henson DE, Hutter RVP, Sobin LH (2003) TNM supplement. A commentary on uniform use, 3 edn. Wiley, New YorkCrossRef
Metadaten
Titel
Proposal for an extended pTNM classification of thyroid carcinoma
Commentary on deficits of the 8th edition of the TNM classification
verfasst von
Prof. Dr. K. W. Schmid
S. Synoracki
H. Dralle
C. Wittekind
Publikationsdatum
19.02.2018
Verlag
Springer Medizin
Erschienen in
Die Pathologie / Ausgabe Sonderheft 1/2019
Print ISSN: 2731-7188
Elektronische ISSN: 2731-7196
DOI
https://doi.org/10.1007/s00292-018-0418-x

Weitere Artikel der Sonderheft 1/2019

Die Pathologie 1/2019 Zur Ausgabe

Main lectures: main programme of the German Society of Pathology

Urachal cancer—current concepts of a rare cancer

Lectures Laureates: Rudolf-Virchow-Laureate 2018

MIF in kidney diseases

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.